$46.06
2.25%
Nasdaq, Nov 19, 04:00 pm EST. Closed.
ISIN
US80105N1054
Symbol
SNY

Sanofi Sponsored ADR Stock price

$46.06
+6.49 16.40% 1M
+2.51 5.76% 6M
-2.40 4.95% YTD
-3.49 7.04% 1Y
-0.44 0.95% 3Y
-4.57 9.03% 5Y
+5.90 14.69% 10Y
+3.43 8.04% 20Y
Nasdaq, Closing price Thu, Nov 19 2026
-1.06 2.25%
ISIN
US80105N1054
Symbol
SNY
Industry

Is Sanofi Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,085 stocks worldwide.

Key metrics

Basic
Market capitalization
$114.0b
Enterprise Value
$129.2b
Net debt
$15.2b
Cash
$6.5b
Shares outstanding
1.2b
Valuation
P/E
7.4
P/S | estimate
1.6 | 2.1
EV/Sales | estimate
1.8 | 2.4
EV/FCF | ex SBC
9.8 | -
P/B
1.4
Dividends
DPS
$2.42
Yield 1Y | 5Y
5.1% | 4.3%
Growth 1Y | 5Y
10.2% | 4.6%
Payout 1Y | 3Y
31.4% | 37.1%
Increased
3 Years
Financials
Revenue | estimate
$70.4b | $54.3b
EBITDA
$19.5b
EBIT
$16.6b
Net Income
$7.7b
Free Cash Flow | ex SBC
$13.1b | -
Growth
Revenue | estimate
8.4% | 6.0%
EBITDA
11.1%
EBIT
8.3%
Net Income
-44.3%
Free Cash Flow
-21.0%
Margin
Gross
73.6%
EBITDA
27.8%
EBIT
23.7%
Net
10.9%
Free Cash Flow | ex SBC
18.6% | -
Financial Health
Equity Ratio
56.3%
Return on Equity
11.0%
ROCE
15.1%
ROIC
11.6%
Debt/Equity
0.3
More
EPS
$6.4
FCF per Share
$10.9
Short interest
0.6%
Employees
75k
Rev per Employee
$690.0k

Sanofi Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

31 Analysts have issued a Sanofi Sponsored ADR forecast:

17x Buy
55%
13x Hold
42%
1x Sell
3%

Analyst Opinions

31 Analysts have issued a Sanofi Sponsored ADR forecast:

Buy
55%
Hold
42%
Sell
3%

Sanofi Sponsored ADR Events

Past Events
OCT
30
Q3 2026 Earnings Call
21 days ago
SEP
22
Bank of America Global Healthcare Conference 2026
about 2 months ago
SEP
15
Morgan Stanley 24th Annual Global Healthcare Conference
2 months ago
JUL
30
Q2 2026 Earnings Call
4 months ago
APR
29
Shareholder/Analyst Call - Sanofi
7 months ago
APR
23
Q1 2026 Earnings Call
7 months ago
JAN
29
Q4 2025 Earnings Call
10 months ago
JAN
12
44th Annual J.P. Morgan Healthcare Conference
10 months ago
DEC
16
Special Call - Sanofi
11 months ago
DEC
3
Citi Annual Global Healthcare Conference 2025
12 months ago
DEC
2
Evercore 8th Annual Healthcare Conference
12 months ago
OCT
24
Q3 2025 Earnings Call
about one year ago

Financial data from Sanofi Sponsored ADR

Sep '26
+/-
%
70,367 70,367
8% 8%
100%
- Direct Costs 18,598 18,598
3% 3%
26%
51,769 51,769
10% 10%
74%
- Selling and Administrative Expenses 13,314 13,314
8% 8%
19%
- Research and Development Expense 10,918 10,918
1% 1%
16%
19,546 19,546
11% 11%
28%
- Depreciation and Amortization 2,898 2,898
30% 30%
4%
EBIT (Operating Income) EBIT 16,648 16,648
8% 8%
24%
Net Profit 7,655 7,655
44% 44%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Sanofi Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanofi Sponsored ADR Stock News

Positive
Proactive Investors
●
about 3 hours ago
Insmed Incorporated (NASDAQ:INSM) shares surged on Thursday after reports that French pharmaceutical group Sanofi is considering an acquisition of the US biotechnology company, which has a market value of about $26.28 billion. On Thursday afternoon, Insmed was trading at $141.84, up $22.04, or 18.4%.
Negative
CNBC
●
about 9 hours ago
A shortage of Sanofi's Pompe disease drugs has lasted for more than three months, forcing some patients to miss critical infusions. Sanofi says the shortage is due to manufacturing issues at its facility in Ireland.
Positive
Investors Business Daily
●
about 9 hours ago
Insmed stock surged Thursday on a rumored bid from French pharma giant Sanofi. The deal would be one of the largest in recent history.
More Sanofi Sponsored ADR News

Company Profile

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Head office France
CEO Mr. Hudson
Employees 74,846
Founded 1994
Website www.sanofi.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today